Abstract
The endovascular treatment of atherosclerotic intracranial arterial stenoses has previously been based on balloon dilatation or the deployment of a balloon expandable stent. Both methods have advantages (balloon: flexibility; balloon expandable stent: high radial force) and drawbacks (balloon: risk of elastic recoil and dissection; balloon expandable stent: limited flexibility, risk of injury to the vessel due to excessive straightening, overexpansion at ends of stent). A new combination of balloon dilatation, followed by the deployment of a self-expanding microstent has been applied in 15 patients with atherosclerotic arterial stenoses, symptomatic despite medical treatment. An anatomically and clinically adequate result was achieved in all patients. The initial degree of stenosis was 72% (mean). Balloon dilatation resulted in an average residual stenosis of 54% (mean), reduced further to a mean of 38% after stent deployment. Arterial dissection, occlusion of the target artery or symptomatic distal emboli was not encountered. In one patient, a side branch occlusion occurred after dilatation of a M1 stenosis, with complete neurological recovery. All patients were either stable or improved 4 weeks after the treatment. Recurrent TIA did not occur in any patient. Balloon dilatation and subsequent deployment of a self-expandable stent for the treatment of symptomatic intracranial arterial stenoses combines the advantages of both techniques and allows a rapid, clinically effective and technically safe treatment of these frequently challenging lesions.
Similar content being viewed by others
References
Kremer C, Schaettin T, Georgiadis D, Baumgartner RW (2004) Prognosis of symptomatic stenosis of the middle cerebral artery. J Neurol Neurosurg Psychiatry 75:1300–1303
Lutsep HL, Clark WM (2000) Association of intracranial stenosis with cortical symptoms or signs. Neurology 55:716–718
Marzewski DJ, Furlan AJ, St Louis P, Little JR, Modic MT, Williams G (1982) Intracranial internal carotid artery stenosis. Long term prognosis. Stroke 13:821–824
Petty GW, Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO (2000) Ischemic stroke subtypes. A population-based study of functional outcome, survival, and recurrence. Stroke 31:1062–1068
Thijs VN, Albers GW (2000) Symptomatic intracranial atherosclerosis. Outcome of patients who fail antithrombotic therapy. Neurology 55:490–497
Warfarin–Aspirin symptomatic intracranial disease (WASID) study group (1998) Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 29:1389–1392
Meyring S, Jacoby N, Tillmann F, Henkes H, Leopold HC (2002) Local intra-arterial fibrinolysis of acute basilar artery occlusion under oral anticoagulation. Akt Neurol 29:203–207
Henkes H, Bose A, Felber S, Miloslavski E, Berg-Dammer E, Kühne D (2002) Endovascular coil occlusion of intracranial aneurysms assisted by a novel self-expandable nitinol microstent (Neuroform). Interv Neuroradiol 8:107–119
The EC/IC bypass study group (1985) Failure of extracranial–intracranial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 313:1191–1200
Berg-Dammer E, Henkes H, Weber W, Berlit P, Kühne D (1998) Percutaneous transluminal angioplasty of intracranial artery stenosis: clinical results in 24 patients. Neurosurg Focus 5, Article 13
Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW (1999) Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 30:1065–1069
Alazzaz A, Thornton J, Aletich VA, Debrun GM, Ausman JL, Charbell F (2000) Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. Arch Neurol 57:1625–1630
Gupta R, Schumacher HC, Mangla S et al. (2003) Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 61:1729–1735
Joseph GJ, Goldstein J, Cloft H, Tong F, Dion J (2000) Endovascular stenting of atherosclerotic stenosis in a basilar artery after unsuccessful angioplasty. Am J Radiol 174:384–385
Piotin M, Blanc R, Kothimbakam R, Martin D, Ross IB, Moret J (2000) Primary basilar artery stenting: immediate and long-term results in one patients. Am J Radiol 175:1367–1369
Lylyk P, Cohen JE, Ceratto R, Ferrario A, Miranda C (2002) Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. Am J Neuroradiol 23:430–436
Jiang WJ, Wang YJ, Du B et al. (2004) Stenting of symptomatic M1 stenosis of middle cerebral artery. An initial experience of 40 of patients. Stroke 35:1375–1380
The SSYLVIA study investigators (2004) Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA). Study results. Stroke 35:1388–1392
Foley DP, Rensing BJ, Pieper M et al. (1999) Clinical and quantitative angiographic outcomes following elective implantation of the self-expanding Wallstent for longer coronary artery lesions—final results of the Wellstent native study. Int J Cardiovasc Intervent 2:171–179
Meyer JM, Nowak B, Schuermann K et al. (2003) Inhibition of neointimal proliferation with 188Re-labeled self-expanding nitinol stent in a sheep model. Radiology 229:847–854
Harnek J, Zoucas E, Stenram U, Cwikiel W (2002) Insertion of self-expandable nitinol stents without previous balloon angioplasty reduces restenosis compared with PTA prior to stenting. Cardiovasc Intervent Radiol 25:430–436
Acknowledgements
The authors are most grateful to Dr. H. Preiss for excellent anesthesiological service.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Henkes, H., Miloslavski, E., Lowens, S. et al. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 47, 222–228 (2005). https://doi.org/10.1007/s00234-005-1351-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-005-1351-2